Join to view full profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Ding is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2007 - 2011- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2004 - 2007
Beijing Medical UniversityClass of 1994
Certifications & Licensure
CA State Medical License 2024 - 2028
MN State Medical License 2006 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Incorporate Lab Results, Mayo Clinic, 2013-2017
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2013-2017
- CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2013-2017
Clinical Trials
- Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2014 Jan 15
- Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas Start of enrollment: 2015 Feb 19
- Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies Start of enrollment: 2016 Apr 14
Publications & Presentations
PubMed
- A pilot study to determine the feasibility and safety of pharmacist and nurse driven management of venetoclax ramp-up in patients with chronic lymphocytic leukemia.Rachel J Bailen, Monica I Aasum, Linda M Tamminga, Amber B Koehler, Amy L Behnken
Journal of Oncology Pharmacy Practice. 2026-07-01 - Genomic profiling reveals molecular heterogeneity in patients with Richter transformation (RT) and chronic lymphocytic leukemia (CLL).Shulan Tian, Hanyin Wang, Sameer A Parikh, Yuanhang Liu, Helen Jin-Lee
Leukemia Research. 2026-01-01 - 2 citationsComparison of Frontline Therapies in Older Adults Age ≥ 80 Years With Chronic Lymphocytic Leukemia (CLL): A Mayo Clinic and Danish Nation-Wide Study.Mazie Tsang, Paul J Hampel, Kari G Rabe, Christian Brieghel, Wei Ding
American Journal of Hematology. 2025-09-01
Journal Articles
- Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical CentreSameer A Parikh, Tait D Shanafelt, Paul J Hampel, Jose F Leis, Neil E Kay, Wei Ding, Timothy G Call, Deborah Bowen, Eli Muchtar, British Journal of Haematology
Abstracts/Posters
- BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of ProgressionWei Ding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- A Role for TNF-_ in Chronic Lymphocytic Leukemia Bone Marrow Hematopoietic DysfunctionWei Ding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell LymphocytosisWei Ding, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- The Future of Chronic Lymphocytic Leukemia (CLL) Therapy60th American Society of Hematology Annual Meeting - 12/3/2018
- The Future of Chronic Lymphocytic Leukemia (CLL) Therapy60th American Society of Hematology Annual Meeting - 12/1/2018
- Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
DGAT1 Mutations Leading to Delayed Chronic Diarrhoea: A Case ReportDecember 1st, 2020
DGAT1 Mutations Leading to Delayed Chronic Diarrhoea: A Case ReportDecember 1st, 2020- Incidence and Risk of Tumor Lysis Syndrome in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL) Treated with Venetoclax in Routine Clinical PracticeFebruary 25th, 2020
Grant Support
- Use of accelerometer and gyroscope data to improve precision of estimates of physical activity type and energy expenditure in free-living adultsUNIVERSITY OF TENNESSEE KNOXVILLE2022–2026
- Use of accelerometer and gyroscope data to improve precision of estimates of physical activity type and energy expenditure in free-living adultsUNIVERSITY OF TENNESSEE KNOXVILLE2022–2026
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
